- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report offers an overview of the market trends, drivers, and barriers with respect to the USA Waldenstrom Macroglobulinemia Therapeutics market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Waldenstrom Macroglobulinemia Therapeutics market. Detailed analysis of key players, along with key growth strategies adopted by Waldenstrom Macroglobulinemia Therapeutics industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Hutchison MediPharma Limited
Gilead Sciences, Inc
Calithera Biosciences, Inc
BeiGene(Beijing) Co,Ltd
Karyopharm Therapeutics, Inc
Genmab A/S
Genentech, Inc
Merck KGaA
IGF Oncology, LLC
Incyte Corporation
Millennium Pharmaceuticals, Inc
Idera Pharmaceuticals, Inc
Celgene Corporation
By Type:
CB-839
Copanlisib Hydrochloride
DI-B4
Entospletinib
Everolimus
FV-162
Others
By End-User:
Clinic
Hospital
Others
By Region:
-
West USA
-
South USA
-
Middle West USA
-
Northeast USA
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Waldenstrom Macroglobulinemia Therapeutics Market
-
1.3 Market Segment by Type
-
1.3.1 USA Waldenstrom Macroglobulinemia Therapeutics Market Size and Growth Rate of CB-839 from 2016 to 2027
-
1.3.2 USA Waldenstrom Macroglobulinemia Therapeutics Market Size and Growth Rate of Copanlisib Hydrochloride from 2016 to 2027
-
1.3.3 USA Waldenstrom Macroglobulinemia Therapeutics Market Size and Growth Rate of DI-B4 from 2016 to 2027
-
1.3.4 USA Waldenstrom Macroglobulinemia Therapeutics Market Size and Growth Rate of Entospletinib from 2016 to 2027
-
1.3.5 USA Waldenstrom Macroglobulinemia Therapeutics Market Size and Growth Rate of Everolimus from 2016 to 2027
-
1.3.6 USA Waldenstrom Macroglobulinemia Therapeutics Market Size and Growth Rate of FV-162 from 2016 to 2027
-
1.3.7 USA Waldenstrom Macroglobulinemia Therapeutics Market Size and Growth Rate of Others from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 USA Waldenstrom Macroglobulinemia Therapeutics Market Size and Growth Rate of Clinic from 2016 to 2027
-
1.4.2 USA Waldenstrom Macroglobulinemia Therapeutics Market Size and Growth Rate of Hospital from 2016 to 2027
-
1.4.3 USA Waldenstrom Macroglobulinemia Therapeutics Market Size and Growth Rate of Others from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 West USA Waldenstrom Macroglobulinemia Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 South USA Waldenstrom Macroglobulinemia Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 Middle West USA Waldenstrom Macroglobulinemia Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 Northeast USA Waldenstrom Macroglobulinemia Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Waldenstrom Macroglobulinemia Therapeutics Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Waldenstrom Macroglobulinemia Therapeutics by Major Types
-
3.4.1 Market Size and Growth Rate of CB-839
-
3.4.2 Market Size and Growth Rate of Copanlisib Hydrochloride
-
3.4.3 Market Size and Growth Rate of DI-B4
-
3.4.4 Market Size and Growth Rate of Entospletinib
-
3.4.5 Market Size and Growth Rate of Everolimus
-
3.4.6 Market Size and Growth Rate of FV-162
-
3.4.7 Market Size and Growth Rate of Others
4 Segmentation of Waldenstrom Macroglobulinemia Therapeutics Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Waldenstrom Macroglobulinemia Therapeutics by Major End-Users
-
4.4.1 Market Size and Growth Rate of Waldenstrom Macroglobulinemia Therapeutics in Clinic
-
4.4.2 Market Size and Growth Rate of Waldenstrom Macroglobulinemia Therapeutics in Hospital
-
4.4.3 Market Size and Growth Rate of Waldenstrom Macroglobulinemia Therapeutics in Others
5 Market Analysis by Regions
-
5.1 USA Waldenstrom Macroglobulinemia Therapeutics Production Analysis by Regions
-
5.2 USA Waldenstrom Macroglobulinemia Therapeutics Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on USA Economy
6 West USA Waldenstrom Macroglobulinemia Therapeutics Landscape Analysis
-
6.1 West USA Waldenstrom Macroglobulinemia Therapeutics Landscape Analysis by Major Types
-
6.2 West USA Waldenstrom Macroglobulinemia Therapeutics Landscape Analysis by Major End-Users
7 South USA Waldenstrom Macroglobulinemia Therapeutics Landscape Analysis
-
7.1 South USA Waldenstrom Macroglobulinemia Therapeutics Landscape Analysis by Major Types
-
7.2 South USA Waldenstrom Macroglobulinemia Therapeutics Landscape Analysis by Major End-Users
8 Middle West USA Waldenstrom Macroglobulinemia Therapeutics Landscape Analysis
-
8.1 Middle West USA Waldenstrom Macroglobulinemia Therapeutics Landscape Analysis by Major Types
-
8.2 Middle West USA Waldenstrom Macroglobulinemia Therapeutics Landscape Analysis by Major End-Users
9 Northeast USA Waldenstrom Macroglobulinemia Therapeutics Landscape Analysis
-
9.1 Northeast USA Waldenstrom Macroglobulinemia Therapeutics Landscape Analysis by Major Types
-
9.2 Northeast USA Waldenstrom Macroglobulinemia Therapeutics Landscape Analysis by Major End-Users
10 Major Players Profiles
-
10.1 Hutchison MediPharma Limited
-
10.1.1 Hutchison MediPharma Limited Company Profile and Recent Development
-
10.1.2 Market Performance
-
10.1.3 Product and Service Introduction
-
10.2 Gilead Sciences, Inc
-
10.2.1 Gilead Sciences, Inc Company Profile and Recent Development
-
10.2.2 Market Performance
-
10.2.3 Product and Service Introduction
-
10.3 Calithera Biosciences, Inc
-
10.3.1 Calithera Biosciences, Inc Company Profile and Recent Development
-
10.3.2 Market Performance
-
10.3.3 Product and Service Introduction
-
10.4 BeiGene(Beijing) Co,Ltd
-
10.4.1 BeiGene(Beijing) Co,Ltd Company Profile and Recent Development
-
10.4.2 Market Performance
-
10.4.3 Product and Service Introduction
-
10.5 Karyopharm Therapeutics, Inc
-
10.5.1 Karyopharm Therapeutics, Inc Company Profile and Recent Development
-
10.5.2 Market Performance
-
10.5.3 Product and Service Introduction
-
10.6 Genmab A/S
-
10.6.1 Genmab A/S Company Profile and Recent Development
-
10.6.2 Market Performance
-
10.6.3 Product and Service Introduction
-
10.7 Genentech, Inc
-
10.7.1 Genentech, Inc Company Profile and Recent Development
-
10.7.2 Market Performance
-
10.7.3 Product and Service Introduction
-
10.8 Merck KGaA
-
10.8.1 Merck KGaA Company Profile and Recent Development
-
10.8.2 Market Performance
-
10.8.3 Product and Service Introduction
-
10.9 IGF Oncology, LLC
-
10.9.1 IGF Oncology, LLC Company Profile and Recent Development
-
10.9.2 Market Performance
-
10.9.3 Product and Service Introduction
-
10.10 Incyte Corporation
-
10.10.1 Incyte Corporation Company Profile and Recent Development
-
10.10.2 Market Performance
-
10.10.3 Product and Service Introduction
-
10.11 Millennium Pharmaceuticals, Inc
-
10.11.1 Millennium Pharmaceuticals, Inc Company Profile and Recent Development
-
10.11.2 Market Performance
-
10.11.3 Product and Service Introduction
-
10.12 Idera Pharmaceuticals, Inc
-
10.12.1 Idera Pharmaceuticals, Inc Company Profile and Recent Development
-
10.12.2 Market Performance
-
10.12.3 Product and Service Introduction
-
10.13 Celgene Corporation
-
10.13.1 Celgene Corporation Company Profile and Recent Development
-
10.13.2 Market Performance
-
10.13.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure USA Waldenstrom Macroglobulinemia Therapeutics Market Size and Growth Rate of CB-839 from 2016 to 2027
-
Figure USA Waldenstrom Macroglobulinemia Therapeutics Market Size and Growth Rate of Copanlisib Hydrochloride from 2016 to 2027
-
Figure USA Waldenstrom Macroglobulinemia Therapeutics Market Size and Growth Rate of DI-B4 from 2016 to 2027
-
Figure USA Waldenstrom Macroglobulinemia Therapeutics Market Size and Growth Rate of Entospletinib from 2016 to 2027
-
Figure USA Waldenstrom Macroglobulinemia Therapeutics Market Size and Growth Rate of Everolimus from 2016 to 2027
-
Figure USA Waldenstrom Macroglobulinemia Therapeutics Market Size and Growth Rate of FV-162 from 2016 to 2027
-
Figure USA Waldenstrom Macroglobulinemia Therapeutics Market Size and Growth Rate of Others from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2020
-
Figure Market Share by Type in 2027
-
Figure USA Waldenstrom Macroglobulinemia Therapeutics Market Size and Growth Rate of Clinic from 2016 to 2027
-
Figure USA Waldenstrom Macroglobulinemia Therapeutics Market Size and Growth Rate of Hospital from 2016 to 2027
-
Figure USA Waldenstrom Macroglobulinemia Therapeutics Market Size and Growth Rate of Others from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2020
-
Figure Market Share by End-User in 2027
-
Figure West USA Waldenstrom Macroglobulinemia Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South USA Waldenstrom Macroglobulinemia Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Middle West USA Waldenstrom Macroglobulinemia Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast USA Waldenstrom Macroglobulinemia Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Waldenstrom Macroglobulinemia Therapeutics Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2019
-
Figure Market Share of TOP 5 Players in 2019
-
Figure Market Share of TOP 6 Players from 2016 to 2020
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Distribution Map of USA
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Waldenstrom Macroglobulinemia Therapeutics
-
Figure Development Trends of Different Types
-
Table Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Waldenstrom Macroglobulinemia Therapeutics by Different Types from 2016 to 2027
-
Table Consumption Share of Waldenstrom Macroglobulinemia Therapeutics by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of CB-839
-
Figure Market Size and Growth Rate of Copanlisib Hydrochloride
-
Figure Market Size and Growth Rate of DI-B4
-
Figure Market Size and Growth Rate of Entospletinib
-
Figure Market Size and Growth Rate of Everolimus
-
Figure Market Size and Growth Rate of FV-162
-
Figure Market Size and Growth Rate of Others
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Waldenstrom Macroglobulinemia Therapeutics by Different End-Users from 2016 to 2027
-
Table Consumption Share of Waldenstrom Macroglobulinemia Therapeutics by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Clinic
-
Figure Market Size and Growth Rate of Hospital
-
Figure Market Size and Growth Rate of Others
-
Table USA Waldenstrom Macroglobulinemia Therapeutics Production by Regions
-
Table USA Waldenstrom Macroglobulinemia Therapeutics Production Share by Regions
-
Figure USA Waldenstrom Macroglobulinemia Therapeutics Production Share by Regions in 2016
-
Figure USA Waldenstrom Macroglobulinemia Therapeutics Production Share by Regions in 2021
-
Figure USA Waldenstrom Macroglobulinemia Therapeutics Production Share by Regions in 2027
-
Table USA Waldenstrom Macroglobulinemia Therapeutics Consumption by Regions
-
Table USA Waldenstrom Macroglobulinemia Therapeutics Consumption Share by Regions
-
Figure USA Waldenstrom Macroglobulinemia Therapeutics Consumption Share by Regions in 2016
-
Figure USA Waldenstrom Macroglobulinemia Therapeutics Consumption Share by Regions in 2021
-
Figure USA Waldenstrom Macroglobulinemia Therapeutics Consumption Share by Regions in 2027
-
Table West USA Waldenstrom Macroglobulinemia Therapeutics Consumption by Types from 2016 to 2027
-
Table West USA Waldenstrom Macroglobulinemia Therapeutics Consumption Share by Types from 2016 to 2027
-
Figure West USA Waldenstrom Macroglobulinemia Therapeutics Consumption Share by Types in 2016
-
Figure West USA Waldenstrom Macroglobulinemia Therapeutics Consumption Share by Types in 2021
-
Figure West USA Waldenstrom Macroglobulinemia Therapeutics Consumption Share by Types in 2027
-
Table West USA Waldenstrom Macroglobulinemia Therapeutics Consumption by End-Users from 2016 to 2027
-
Table West USA Waldenstrom Macroglobulinemia Therapeutics Consumption Share by End-Users from 2016 to 2027
-
Figure West USA Waldenstrom Macroglobulinemia Therapeutics Consumption Share by End-Users in 2016
-
Figure West USA Waldenstrom Macroglobulinemia Therapeutics Consumption Share by End-Users in 2021
-
Figure West USA Waldenstrom Macroglobulinemia Therapeutics Consumption Share by End-Users in 2027
-
Table South USA Waldenstrom Macroglobulinemia Therapeutics Consumption by Types from 2016 to 2027
-
Table South USA Waldenstrom Macroglobulinemia Therapeutics Consumption Share by Types from 2016 to 2027
-
Figure South USA Waldenstrom Macroglobulinemia Therapeutics Consumption Share by Types in 2016
-
Figure South USA Waldenstrom Macroglobulinemia Therapeutics Consumption Share by Types in 2021
-
Figure South USA Waldenstrom Macroglobulinemia Therapeutics Consumption Share by Types in 2027
-
Table South USA Waldenstrom Macroglobulinemia Therapeutics Consumption by End-Users from 2016 to 2027
-
Table South USA Waldenstrom Macroglobulinemia Therapeutics Consumption Share by End-Users from 2016 to 2027
-
Figure South USA Waldenstrom Macroglobulinemia Therapeutics Consumption Share by End-Users in 2016
-
Figure South USA Waldenstrom Macroglobulinemia Therapeutics Consumption Share by End-Users in 2021
-
Figure South USA Waldenstrom Macroglobulinemia Therapeutics Consumption Share by End-Users in 2027
-
Table Middle West USA Waldenstrom Macroglobulinemia Therapeutics Consumption by Types from 2016 to 2027
-
Table Middle West USA Waldenstrom Macroglobulinemia Therapeutics Consumption Share by Types from 2016 to 2027
-
Figure Middle West USA Waldenstrom Macroglobulinemia Therapeutics Consumption Share by Types in 2016
-
Figure Middle West USA Waldenstrom Macroglobulinemia Therapeutics Consumption Share by Types in 2021
-
Figure Middle West USA Waldenstrom Macroglobulinemia Therapeutics Consumption Share by Types in 2027
-
Table Middle West USA Waldenstrom Macroglobulinemia Therapeutics Consumption by End-Users from 2016 to 2027
-
Table Middle West USA Waldenstrom Macroglobulinemia Therapeutics Consumption Share by End-Users from 2016 to 2027
-
Figure Middle West USA Waldenstrom Macroglobulinemia Therapeutics Consumption Share by End-Users in 2016
-
Figure Middle West USA Waldenstrom Macroglobulinemia Therapeutics Consumption Share by End-Users in 2021
-
Figure Middle West USA Waldenstrom Macroglobulinemia Therapeutics Consumption Share by End-Users in 2027
-
Table Northeast USA Waldenstrom Macroglobulinemia Therapeutics Consumption by Types from 2016 to 2027
-
Table Northeast USA Waldenstrom Macroglobulinemia Therapeutics Consumption Share by Types from 2016 to 2027
-
Figure Northeast USA Waldenstrom Macroglobulinemia Therapeutics Consumption Share by Types in 2016
-
Figure Northeast USA Waldenstrom Macroglobulinemia Therapeutics Consumption Share by Types in 2021
-
Figure Northeast USA Waldenstrom Macroglobulinemia Therapeutics Consumption Share by Types in 2027
-
Table Northeast USA Waldenstrom Macroglobulinemia Therapeutics Consumption by End-Users from 2016 to 2027
-
Table Northeast USA Waldenstrom Macroglobulinemia Therapeutics Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast USA Waldenstrom Macroglobulinemia Therapeutics Consumption Share by End-Users in 2016
-
Figure Northeast USA Waldenstrom Macroglobulinemia Therapeutics Consumption Share by End-Users in 2021
-
Figure Northeast USA Waldenstrom Macroglobulinemia Therapeutics Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Hutchison MediPharma Limited
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Hutchison MediPharma Limited
-
Figure Sales and Growth Rate Analysis of Hutchison MediPharma Limited
-
Figure Revenue and Market Share Analysis of Hutchison MediPharma Limited
-
Table Product and Service Introduction of Hutchison MediPharma Limited
-
Table Company Profile and Development Status of Gilead Sciences, Inc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Gilead Sciences, Inc
-
Figure Sales and Growth Rate Analysis of Gilead Sciences, Inc
-
Figure Revenue and Market Share Analysis of Gilead Sciences, Inc
-
Table Product and Service Introduction of Gilead Sciences, Inc
-
Table Company Profile and Development Status of Calithera Biosciences, Inc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Calithera Biosciences, Inc
-
Figure Sales and Growth Rate Analysis of Calithera Biosciences, Inc
-
Figure Revenue and Market Share Analysis of Calithera Biosciences, Inc
-
Table Product and Service Introduction of Calithera Biosciences, Inc
-
Table Company Profile and Development Status of BeiGene(Beijing) Co,Ltd
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of BeiGene(Beijing) Co,Ltd
-
Figure Sales and Growth Rate Analysis of BeiGene(Beijing) Co,Ltd
-
Figure Revenue and Market Share Analysis of BeiGene(Beijing) Co,Ltd
-
Table Product and Service Introduction of BeiGene(Beijing) Co,Ltd
-
Table Company Profile and Development Status of Karyopharm Therapeutics, Inc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Karyopharm Therapeutics, Inc
-
Figure Sales and Growth Rate Analysis of Karyopharm Therapeutics, Inc
-
Figure Revenue and Market Share Analysis of Karyopharm Therapeutics, Inc
-
Table Product and Service Introduction of Karyopharm Therapeutics, Inc
-
Table Company Profile and Development Status of Genmab A/S
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Genmab A/S
-
Figure Sales and Growth Rate Analysis of Genmab A/S
-
Figure Revenue and Market Share Analysis of Genmab A/S
-
Table Product and Service Introduction of Genmab A/S
-
Table Company Profile and Development Status of Genentech, Inc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Genentech, Inc
-
Figure Sales and Growth Rate Analysis of Genentech, Inc
-
Figure Revenue and Market Share Analysis of Genentech, Inc
-
Table Product and Service Introduction of Genentech, Inc
-
Table Company Profile and Development Status of Merck KGaA
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck KGaA
-
Figure Sales and Growth Rate Analysis of Merck KGaA
-
Figure Revenue and Market Share Analysis of Merck KGaA
-
Table Product and Service Introduction of Merck KGaA
-
Table Company Profile and Development Status of IGF Oncology, LLC
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of IGF Oncology, LLC
-
Figure Sales and Growth Rate Analysis of IGF Oncology, LLC
-
Figure Revenue and Market Share Analysis of IGF Oncology, LLC
-
Table Product and Service Introduction of IGF Oncology, LLC
-
Table Company Profile and Development Status of Incyte Corporation
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Incyte Corporation
-
Figure Sales and Growth Rate Analysis of Incyte Corporation
-
Figure Revenue and Market Share Analysis of Incyte Corporation
-
Table Product and Service Introduction of Incyte Corporation
-
Table Company Profile and Development Status of Millennium Pharmaceuticals, Inc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Millennium Pharmaceuticals, Inc
-
Figure Sales and Growth Rate Analysis of Millennium Pharmaceuticals, Inc
-
Figure Revenue and Market Share Analysis of Millennium Pharmaceuticals, Inc
-
Table Product and Service Introduction of Millennium Pharmaceuticals, Inc
-
Table Company Profile and Development Status of Idera Pharmaceuticals, Inc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Idera Pharmaceuticals, Inc
-
Figure Sales and Growth Rate Analysis of Idera Pharmaceuticals, Inc
-
Figure Revenue and Market Share Analysis of Idera Pharmaceuticals, Inc
-
Table Product and Service Introduction of Idera Pharmaceuticals, Inc
-
Table Company Profile and Development Status of Celgene Corporation
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Celgene Corporation
-
Figure Sales and Growth Rate Analysis of Celgene Corporation
-
Figure Revenue and Market Share Analysis of Celgene Corporation
-
Table Product and Service Introduction of Celgene Corporation
-

Chinese